[PDF][PDF] Single-cell heterogeneity analysis and CRISPR screen identify key β-cell-specific disease genes

Z Fang, C Weng, H Li, R Tao, W Mai, X Liu, L Lu, S Lai… - Cell reports, 2019 - cell.com
Z Fang, C Weng, H Li, R Tao, W Mai, X Liu, L Lu, S Lai, Q Duan, C Alvarez, P Arvan
Cell reports, 2019cell.com
Identification of human disease signature genes typically requires samples from many
donors to achieve statistical significance. Here, we show that single-cell heterogeneity
analysis may overcome this hurdle by significantly improving the test sensitivity. We
analyzed the transcriptome of 39,905 single islets cells from 9 donors and observed distinct
β cell heterogeneity trajectories associated with obesity or type 2 diabetes (T2D). We
therefore developed RePACT, a sensitive single-cell analysis algorithm to identify both …
Summary
Identification of human disease signature genes typically requires samples from many donors to achieve statistical significance. Here, we show that single-cell heterogeneity analysis may overcome this hurdle by significantly improving the test sensitivity. We analyzed the transcriptome of 39,905 single islets cells from 9 donors and observed distinct β cell heterogeneity trajectories associated with obesity or type 2 diabetes (T2D). We therefore developed RePACT, a sensitive single-cell analysis algorithm to identify both common and specific signature genes for obesity and T2D. We mapped both β-cell-specific genes and disease signature genes to the insulin regulatory network identified from a genome-wide CRISPR screen. Our integrative analysis discovered the previously unrecognized roles of the cohesin loading complex and the NuA4/Tip60 histone acetyltransferase complex in regulating insulin transcription and release. Our study demonstrated the power of combining single-cell heterogeneity analysis and functional genomics to dissect the etiology of complex diseases.
cell.com